porfiromycin has been researched along with Adenocarcinoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baker, LH; Izbicki, RM; Vaitkevicius, VK | 1 |
Brattain, MG; Casazza, AM; Long, BH; Lorico, A; Wang, L; Wang, RC | 1 |
Selawry, OS | 1 |
al-Sarraf, M; Izbicki, R; Reed, ML; Vaitkevicius, VK; Vaughn, CB | 1 |
1 review(s) available for porfiromycin and Adenocarcinoma
Article | Year |
---|---|
Monochemotherapy of bronchogenic carcinoma withs special reference to cell type.
Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Carcinoma, Bronchogenic; Cytarabine; Dactinomycin; Daunorubicin; Doxorubicin; Floxuridine; Humans; Hydroxyurea; Lung Neoplasms; Mechlorethamine; Methotrexate; Mitomycins; Nitrosourea Compounds; Plicamycin; Porfiromycin; Procarbazine; Streptonigrin; Thiotepa; Vinblastine | 1973 |
2 trial(s) available for porfiromycin and Adenocarcinoma
Article | Year |
---|---|
Phase II study of profiromycin vs mitomycin-C utilizing acute intermittent schedules.
Topics: Abdominal Neoplasms; Adenocarcinoma; Female; Gastrointestinal Neoplasms; Humans; Injections, Intravenous; Male; Mitomycins; Ovarian Neoplasms; Porfiromycin; Prospective Studies; Remission, Spontaneous | 1976 |
Further clinical trials with porfiromycin (NSC-56410) (large intermittent doses).
Topics: Adenocarcinoma; Adult; Anemia; Astrocytoma; Blood Cell Count; Blood Platelets; Carcinoma; Carcinoma, Squamous Cell; Child; Clinical Trials as Topic; Cystadenoma; Female; Humans; Leukocyte Count; Neoplasms; Osteosarcoma; Porfiromycin; Rhabdomyosarcoma | 1972 |
1 other study(ies) available for porfiromycin and Adenocarcinoma
Article | Year |
---|---|
Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines.
Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Cell Line; Colonic Neoplasms; DNA; DNA Damage; DNA Probes; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Etoposide; Humans; Immunoblotting; Lung Neoplasms; Membrane Glycoproteins; Molecular Sequence Data; Neoplasm Proteins; Porfiromycin; RNA; Teniposide | 1991 |